1 not yet recruiting, 1 withdrawn. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow Relapsing-remitting Multiple Sclerosis (RRMS): new trials by email Literature Review of Relapsing-remitting Multiple Sclerosis (RRMS) trials Research Report on Relapsing-remitting Multiple Sclerosis (RRMS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Memory Retrieval Impairments in MS With HDtDCS to the LIFG in a Placebo Controlled Trial High Definition transcranial Direct Current Stimulation, Sham High Definition transcranial Direct Current Stimulation - Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis (RRMS) | Not applicable | Not yet recruiting | The University of Texas at Dallas | 80 | 2026-11-01 | 2026-11-03 |
| Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab BeCare application - Relapsing-remitting Multiple Sclerosis (RRMS) | Not applicable | Withdrawn | Icahn School of Medicine at Mount Sinai | 2022-10-31 | 2022-11-25 |
Multiple Sclerosis (2) · Multiple Sclerosis, Relapsing-Remitting (2)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2)
Icahn School of Medicine at Mount Sinai (1) · The University of Texas at Dallas (1)
United States (2)